Cost-Effectiveness of Retromuscular Hernia Repair (NCT07530159) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Cost-Effectiveness of Retromuscular Hernia Repair
Spain120 participantsStarted 2026-01-01
Plain-language summary
This prospective observational study aims to evaluate the clinical outcomes and cost-effectiveness of retromuscular midline ventral hernia repair using open, laparoscopic and robotic approaches. Patients undergoing elective repair are included and followed to assess postoperative complications, length of hospital stay, recurrence and quality of life. In addition, a cost-effectiveness analysis will be performed from the perspective of the Spanish National Health System. The study is currently ongoing.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults ≥ 18 years
* Patients scheduled for elective retromuscular repair of midline ventral hernia
* Primary hernia or recurrent hernia without previous retromuscular repair
* Hernia defect width between 5 and 12 cm (EHS W2-W3)
* Ability to understand the study and provide informed consent
Exclusion Criteria:
* Contraindication to general anesthesia
* Contraindication to minimally invasive or open surgery
* Body mass index (BMI) \> 35 kg/m²
* ASA physical status \> IV
* Previous retromuscular hernia repair
* Lateral or parastomal hernias
* Emergency surgery
* Advanced disease with life expectancy \< 2 years
* Pregnancy or planned pregnancy during follow-up
* Conditions significantly affecting wound healing or surgical risk (e.g., severe immunosuppression, active chemotherapy, connective tissue disorders)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Length of hospital stay
Timeframe: From date of surgery until hospital discharge (typically within 30 days postoperative)